Barbara Schwartzberg
Denver, CONPI 1770547663
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $291,304 of the $292,083 with a category attached, or 99.7%. Elekta, Inc. accounts for 61.4% of it on its own, with 5 other manufacturers making up the rest.
Across 41 payments — averaging $7123.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elekta, Inc.$179K
- Novian Health Inc.$112K
- Nucletron Operations B.v.$550
- Stryker$149
- Viiv Healthcare Company$58
- Bayer$21
Across 28 payments — averaging $9047.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Icad, Inc$253K
What the payments were for
- Consulting fees$291,304100%
- Food & beverage$2290%
- Education$5500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elekta, Inc. | 24 | $179,304 |
| Novian Health Inc. | 10 | $112,000 |
| Nucletron Operations B.v. | 1 | $550 |
| Stryker | 2 | $149 |
| Viiv Healthcare Company | 3 | $58 |
| Bayer | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLEXITRON HDR$118,902
- SURG - NEPTUNE$116
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.